There is a staff of over 2,500 at Peter Mac, including more than 580 laboratory and clinical researchers, all focused on providing better treatments, better care and potential cures for cancer.
The internationally renowned cancer laboratories are searching for fundamental biological and biomedical discoveries, and aim to facilitate the development and application of these discoveries to their full therapeutic potential.
Professor Johnstone is the Executive Director Cancer Research and a Group Leader in both the Peter Mac Cancer Immunology Program and Translational Haematology Program.
Read more: Therapeutic targeting transcriptional addiction in paediatric leukaemias.
The Johnstone laboratory fully integrates fundamental cancer and immunological research with pre-clinical development and testing of novel therapeutic regimes, to drive new clinical trials using agents under investigation in the lab.
Major themes in the lab include: